| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Immunovant Inc (NASDAQ: IMVT)
IMVT Technical Analysis
5
| As on 9th Jun 2023 IMVT STOCK Price closed @ 21.30 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 6.20 & Strong Buy for SHORT-TERM with Stoploss of 6.72 we also expect STOCK to react on Following IMPORTANT LEVELS. |
IMVTSTOCK Price
| Open | 21.31 | Change | Price | % |
| High | 21.31 | 1 Day | 0.05 | 0.24 |
| Low | 20.75 | 1 Week | 0.47 | 2.26 |
| Close | 21.30 | 1 Month | 5.21 | 32.38 |
| Volume | 1423900 | 1 Year | 13.44 | 170.99 |
| 52 Week High 23.75 | 52 Week Low 3.38 | ||||
NASDAQ USA Most Active Stocks
| TSLA | 244.40 | 4.06% |
| TTOO | 0.07 | -12.50% |
| SOFI | 8.18 | 0.74% |
| FFIE | 0.33 | 6.45% |
| PONO | 1.72 | 2.38% |
| AMD | 124.92 | 3.20% |
| IDEX | 0.06 | 0.00% |
| NKLA | 0.70 | 14.75% |
| AMZN | 123.43 | -0.66% |
| AAPL | 180.96 | 0.22% |
NASDAQ USA Top Gainers Stocks
NASDAQ USA Top Losers Stocks
| IMVT Daily Charts |
IMVT Intraday Charts |
Whats New @ Bazaartrend |
IMVT Free Analysis |
|
|
IMVT Important Levels Intraday
| RESISTANCE | 22.38 |
| RESISTANCE | 22.03 |
| RESISTANCE | 21.82 |
| RESISTANCE | 21.61 |
| SUPPORT | 20.99 |
| SUPPORT | 20.78 |
| SUPPORT | 20.57 |
| SUPPORT | 20.22 |
IMVT Forecast May 2024
| 4th UP Forecast | 26.52 |
| 3rd UP Forecast | 24.85 |
| 2nd UP Forecast | 23.81 |
| 1st UP Forecast | 22.78 |
| 1st DOWN Forecast | 19.82 |
| 2nd DOWN Forecast | 18.79 |
| 3rd DOWN Forecast | 17.75 |
| 4th DOWN Forecast | 16.08 |
IMVT Weekly Forecast
| 4th UP Forecast | 23.82 |
| 3rd UP Forecast | 23.01 |
| 2nd UP Forecast | 22.51 |
| 1st UP Forecast | 22.01 |
| 1st DOWN Forecast | 20.59 |
| 2nd DOWN Forecast | 20.09 |
| 3rd DOWN Forecast | 19.59 |
| 4th DOWN Forecast | 18.78 |
IMVT Forecast2024
| 4th UP Forecast | 61.82 |
| 3rd UP Forecast | 48.83 |
| 2nd UP Forecast | 40.79 |
| 1st UP Forecast | 32.76 |
| 1st DOWN Forecast | 9.84 |
| 2nd DOWN Forecast | 1.81 |
| 3rd DOWN Forecast | -6.23 |
| 4th DOWN Forecast | -19.22 |
Immunovant Inc ( NASDAQ USA Symbol : IMVT )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
IMVT Business Profile
Immunovant, Inc., a clinical-stage biopharmaceutical company, develops monoclonal antibodies for the treatment of autoimmune diseases. It develops IMVT-1401, a novel fully human monoclonal antibody that selectively binds to and inhibits the neonatal fragment crystallizable receptor, which is in Phase IIa clinical trials for the treatment of myasthenia gravis and thyroid eye disease, as well as has completed initiation of Phase II clinical trials for the treatment of warm autoimmune hemolytic anemia. The company is headquartered in New York, New York. Immunovant, Inc. is a subsidiary of Roivant Sciences Ltd. Address: 320 West 37th Street, New York, NY, United States, 10018
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service